Stanford Downgrades Ceradyne (CRDN) to Sell
Earlier, Stanford Group downgradeed Ceradyne (Nasdaq: CRDN) from Hold to Sell, citing long-term concerns with the XSAPI body armor business.
Shares of Ceradyne have fallen more than 15% today. The stock most recently traded at $20.79.
Ceradyne, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of technical ceramic products, powders, and components for defense, industrial, automotive/diesel, and commercial applications in the United States.
Related Categories
DowngradesStocks Mentioned
Related Entities
Comments
CRDN
Never heard of this group. I noticed quite a few shares traded down this morning which got me to thinking does somebody know something I don't and are they shorting the stock? I bet the leak on this made some people a lot of money. CRDN has about $11 cash per share and will probably add at least 2.00 to that this year. Stock is cheap and I am a buyer of more.
DOWNGRADE
WHO IN THE WORLD IS THE STANFORD GROUP ? BECAUSE THEY OPENED THEIR BIG MOUTH I AM DOWN 15 %, AND GOING LOWER. THANKS A LOT !
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Stanford Group
Jeff on Feb 18, 2009 02:52 PMThinking you guys have by now heard of Stanford Group given the latest new... They have no credibility given the recent allegations. It is too bad that Stanford wasn't exposed prior to "downgrading" CRDN